Your search returned 23 results.

Results
	1.	Applicability of Turkish Pricing Policy on Price Increases. [electronic resource] by Beykoz, V Saylan, M Producer: 20160610 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Mother and baby units for schizophrenia. [electronic resource] by Joy, C B Saylan, M Producer: 20070508 In: The Cochrane database of systematic reviews no. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY. [electronic resource] by Saylan, M Beykoz, V Keskinaslan, A Producer: 20160610 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Factors associated with achieving minimally symptomatic status by patients with schizophrenia: results from the 3-year intercontinental schizophrenia outpatients health outcomes study. [electronic resource] by Treuer, T Martenyi, F Saylan, M Dyachkova, Y Producer: 20110526 In: International journal of clinical practice vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	[Frequency of obsessive compulsive symptoms and disorder in patients with schizophrenia: importence for prognosis]. [electronic resource] by Uçok, A Tükel, R Ozgen, G Saylan, M Uzuner, G Producer: 20061012 In: L'Encephale vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials. [electronic resource] by Ligueros-Saylan, M Foley, J E Schweizer, A Couturier, A Kothny, W Producer: 20110603 In: Diabetes, obesity & metabolism vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey. [electronic resource] by Tatar, M Sezen, S Senturk, A Balp, M M Saylan, M Keskinaslan, A Producer: 20160610 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population. [electronic resource] by Schweizer, A Dejager, S Foley, J E Couturier, A Ligueros-Saylan, M Kothny, W Producer: 20110603 In: Diabetes, obesity & metabolism vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	EEG phenotype in alcoholism: increased coherence in the depressive subtype. [electronic resource] by Winterer, G Enoch, M-A White, K V Saylan, M Coppola, R Goldman, D Producer: 20031121 In: Acta psychiatrica Scandinavica vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers. [electronic resource] by He, Y-L Zhang, Y Serra, D Wang, Y Ligueros-Saylan, M Dole, W P Producer: 20111101 In: Current medical research and opinion vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction. [electronic resource] by Saylan, M Khalaf, I Kadioglu, A Shoair, K Z Beheiry, A Wang, W C Kopernicky, V Esen, A Producer: 20070329 In: International journal of clinical practice vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Bioequivalence of vildagliptin/metformin fixed-dose combination tablets and a free combination of vildagliptin and metformin in healthy subjects. [electronic resource] by He, Y-L Paladini, S Sabia, H Campestrini, J Zhang, Y Leon, S Ligueros-Saylan, M Jarugula, V Producer: 20080818 In: International journal of clinical pharmacology and therapeutics vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin. [electronic resource] by He, Y-L Sabo, R Campestrini, J Wang, Y Ligueros-Saylan, M Lasseter, K C Dilzer, S C Howard, D Dole, W P Producer: 20071203 In: European journal of clinical pharmacology vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus. [electronic resource] by Kahn, S E Montgomery, B Howell, W Ligueros-Saylan, M Hsu, C H Devineni, D McLeod, J F Horowitz, A Foley, J E Producer: 20011228 In: The Journal of clinical endocrinology and metabolism vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes. [electronic resource] by Serra, D He, Y-L Bullock, J Riviere, G-J Balez, S Schwartz, S Wang, Y Ligueros-Saylan, M Jarugula, V Dole, W P Producer: 20081007 In: International journal of clinical pharmacology and therapeutics vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes. [electronic resource] by Mari, A Sallas, W M He, Y L Watson, C Ligueros-Saylan, M Dunning, B E Deacon, C F Holst, J J Foley, J E Producer: 20050914 In: The Journal of clinical endocrinology and metabolism vol. 90 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Effect of vildagliptin on glucagon concentration during meals in patients with type 1 diabetes. [electronic resource] by Foley, J E Ligueros-Saylan, M He, Y-L Holst, J J Deacon, C F Dunning, B E Leone-Jones, A Yu, T Kelley, D E Producer: 20081114 In: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Impact of Health Policy Changes on the Cost Sales of 5 Top Selling ATC1 Phramaceutical Groups in Turkey. [electronic resource] by Yenilmez, F B Kockaya, G Saylan, M Safak, Yilmaz E Tatar, M Hilal, Vural E Vural, I M Akbulat, A Gursoz, H Artiran, G Kerman, S Producer: 20160610 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Impact Of Health Policy Changes on Unit Sales of 5 Top Selling Atc1 Phramaceutical Groups In Turkey. [electronic resource] by Saylan, M Safak, Yilmaz E Yenilmez, F B Kockaya, G Tatar, M Hilal, Vural E Vural, I M Akbulat, A Gursoz, H Artiran, G Kerman, S Producer: 20160610 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Impact of Health Policy Changes on Trends of Pharmaceutical Market in Turkey. [electronic resource] by Safak, Yilmaz E Kockaya, G Yenilmez, F B Saylan, M Tatar, M Hilal, Vural E Vural, I M Akbulat, A Gursoz, H Artiran, G Kerman, S Producer: 20160610 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 23 results.